Company Overview
Snapshot
Founded in September 2015 by Gideon Barak and Shani Toledano, HT BioImaging operates with 11–50 employees. The company has raised $5.5M across 3 funding rounds from 6 investors. In March 2022, Companion Animal Health made a strategic investment in HT BioImaging's early cancer detection solution.
Business overview
HT BioImaging develops a medical imaging platform technology for early, on-the-spot cancer detection and classification. The company's core technology is the heat diffusion imaging (HDI) scan, which measures heat diffusion in biological tissues and translates the signal into an image. This non-invasive, real-time procedure is designed for use at the point of care and in operating rooms, serving the healthcare industry, particularly hospitals, healthcare providers, and clinics, with a focus on oncology and diagnostics.
Strategic signal
In March 2022, Companion Animal Health announced a strategic investment in HT BioImaging. This signals strong validation for HT BioImaging's early cancer detection technology, particularly its potential application and market relevance within the animal health sector, suggesting a broader commercialization pathway beyond human medicine.
Log in to access full profile ›Company Intelligence Q&A
- What is HT BioImaging's primary technology?
- HT BioImaging develops the heat diffusion imaging (HDI) scan, a system that measures heat diffusion in biological tissues to enable early detection and classification of cancer.
- When was HT BioImaging founded and by whom?
- HT BioImaging was founded in September 2015 by Gideon Barak and Shani Toledano.
- Which investors participated in the July 2020 funding round?
- In July 2020, HT BioImaging received funding from NextLeap Ventures and Magna Capital Partners.
- What was a significant corporate milestone for HT BioImaging in March 2022?
- In March 2022, Companion Animal Health announced a strategic investment in HT BioImaging's early cancer detection solution.
- Which accelerator program did HT BioImaging graduate from in April 2018?
- In April 2018, HT BioImaging graduated from the IBM Alpha Zone corporate accelerator program.